BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Winther-Sørensen M, Galsgaard KD, Santos A, Trammell SAJ, Sulek K, Kuhre RE, Pedersen J, Andersen DB, Hassing AS, Dall M, Treebak JT, Gillum MP, Torekov SS, Windeløv JA, Hunt JE, Kjeldsen SAS, Jepsen SL, Vasilopoulou CG, Knop FK, Ørskov C, Werge MP, Bisgaard HC, Eriksen PL, Vilstrup H, Gluud LL, Holst JJ, Wewer Albrechtsen NJ. Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis. Mol Metab 2020;42:101080. [PMID: 32937194 DOI: 10.1016/j.molmet.2020.101080] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Dos Santos T, MacDonald PE. Novel mouse model expands potential human α-cell research. Islets 2021;13:80-3. [PMID: 33853502 DOI: 10.1080/19382014.2021.1914507] [Reference Citation Analysis]
2 Sanches JM, Zhao LN, Salehi A, Wollheim CB, Kaldis P. Pathophysiology of type 2 diabetes and the impact of altered metabolic interorgan crosstalk. FEBS J 2021. [PMID: 34847289 DOI: 10.1111/febs.16306] [Reference Citation Analysis]
3 Galsgaard KD. The Vicious Circle of Hepatic Glucagon Resistance in Non-Alcoholic Fatty Liver Disease. J Clin Med 2020;9:E4049. [PMID: 33333850 DOI: 10.3390/jcm9124049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Andersen DB, Holst JJ. Peptides in the regulation of glucagon secretion. Peptides 2021;148:170683. [PMID: 34748791 DOI: 10.1016/j.peptides.2021.170683] [Reference Citation Analysis]
5 Tomar M, Somvanshi PR, Kareenhalli V. Physiological significance of bistable circuit design in metabolic homeostasis: role of integrated insulin-glucagon signalling network. Mol Biol Rep. [DOI: 10.1007/s11033-022-07175-w] [Reference Citation Analysis]
6 Gar C, Haschka SJ, Kern-Matschilles S, Rauch B, Sacco V, Prehn C, Adamski J, Seissler J, Wewer Albrechtsen NJ, Holst JJ, Lechner A. The liver-alpha cell axis associates with liver fat and insulin resistance: a validation study in women with non-steatotic liver fat levels. Diabetologia 2021;64:512-20. [PMID: 33275161 DOI: 10.1007/s00125-020-05334-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Bai X, Jia J, Kang Q, Fu Y, Zhou Y, Zhong Y, Zhang C, Li M. Integrated Metabolomics and Lipidomics Analysis Reveal Remodeling of Lipid Metabolism and Amino Acid Metabolism in Glucagon Receptor-Deficient Zebrafish. Front Cell Dev Biol 2020;8:605979. [PMID: 33520988 DOI: 10.3389/fcell.2020.605979] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Korenfeld N, Finkel M, Buchshtab N, Bar-Shimon M, Charni-Natan M, Goldstein I. Fasting Hormones Synergistically Induce Amino Acid Catabolism Genes to Promote Gluconeogenesis. Cell Mol Gastroenterol Hepatol 2021;12:1021-36. [PMID: 33957303 DOI: 10.1016/j.jcmgh.2021.04.017] [Reference Citation Analysis]
9 Kjeldsen SAS, Hansen LH, Esser N, Mongovin S, Winther-Sørensen M, Galsgaard KD, Hunt JE, Kissow H, Ceutz FR, Terzic D, Mark PD, Plomgaard P, Goetze JP, Goossens GH, Blaak EE, Deacon CF, Rosenkilde MM, Zraika S, Holst JJ, Wewer Albrechtsen NJ. Neprilysin Inhibition Increases Glucagon Levels in Humans and Mice With Potential Effects on Amino Acid Metabolism. J Endocr Soc 2021;5:bvab084. [PMID: 34337276 DOI: 10.1210/jendso/bvab084] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Hinds CE, Owen BM, Hope DCD, Pickford P, Jones B, Tan TM, Minnion JS, Bloom SR. A glucagon analogue decreases body weight in mice via signalling in the liver. Sci Rep 2021;11:22577. [PMID: 34799628 DOI: 10.1038/s41598-021-01912-0] [Reference Citation Analysis]
11 Liu Q, Lin G, Chen Y, Feng W, Xu Y, Lyu J, Yang D, Wang MW. Deleterious mutation V369M in the mouse GCGR gene causes abnormal plasma amino acid levels indicative of a possible liver-α-cell axis. Biosci Rep 2021;41:BSR20210758. [PMID: 34002801 DOI: 10.1042/BSR20210758] [Reference Citation Analysis]
12 Ueno S, Seino Y, Hidaka S, Maekawa R, Takano Y, Yamamoto M, Hori M, Yokota K, Masuda A, Himeno T, Tsunekawa S, Kamiya H, Nakamura J, Kuwata H, Fujisawa H, Shibata M, Takayanagi T, Sugimura Y, Yabe D, Hayashi Y, Suzuki A. High Protein Diet Feeding Aggravates Hyperaminoacidemia in Mice Deficient in Proglucagon-Derived Peptides. Nutrients 2022;14:975. [DOI: 10.3390/nu14050975] [Reference Citation Analysis]
13 Del Prato S, Gallwitz B, Holst JJ, Meier JJ. The incretin/glucagon system as a target for pharmacotherapy of obesity. Obes Rev 2021. [PMID: 34713962 DOI: 10.1111/obr.13372] [Reference Citation Analysis]
14 Vega RB, Whytock KL, Gassenhuber J, Goebel B, Tillner J, Agueusop I, Truax AD, Yu G, Carnero E, Kapoor N, Gardell S, Sparks LM, Smith SR. A Metabolomic Signature of Glucagon Action in Healthy Individuals With Overweight/Obesity. J Endocr Soc 2021;5:bvab118. [PMID: 34337278 DOI: 10.1210/jendso/bvab118] [Reference Citation Analysis]